angiotensin i/ii

Angiotensin I/II (1-6) TFA is a chemical compound comprising amino acids 1-6. It is derived from the Angiotensin I/II peptide, which is formed by the cleavage of the precursor angiotensinogen by renin. The resulting Angiotensin I is then hydrolyzed by angiotensin-converting enzyme (ACE) to produce biologically active Angiotensin II. Angiotensin II has been extensively studied for its potential applications in the treatment of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy[1][2][3].

Angiotensin I/II (1-5) 是由血管紧张素 I/II 肽转化而来，有 1-5 个氨基酸组成的多肽。血管紧张素 I 是由肾素对血管紧张素原的作用形成的，血管紧张素 I 可产生血管紧张素 II 。血管紧张素 II 用于高血压、特发性膜性肾病和肾素-血管紧张素系统的研究。

Angiotensin I/II (1-6) 是由血管紧张素 I/II 肽转化而来，含有 1-6 个氨基酸的多肽。血管紧张素 I 被血管紧张素转换酶水解，形成具有生物活性的血管紧张素 II。血管紧张素 II 用于高血压、特发性膜性肾病和肾素-血管紧张素系统的研究。

Angiotensin III is an agonist of angiotensin 1 (AT1) and AT2 receptor.

Angiotensin III TFA is an agonist of angiotensin 1 (AT1) and AT2 receptor.

Angiotensin III, human, mouse (Angiotensin III, human, mouse(3TFA)) 是一种七肽，是血管紧张素 2 型受体 (AT2R) 激动剂，能够作用于 AT2R (IC50:0.648 nM)及 AT1R (IC50:21.1nM)。

Angiotensin III, human, mouse (TFA) 是一种血管紧张素。

[Val4] Angiotensin III为血管紧张素III类肽，作为Gαq和βarr2反应的高效全激动剂，其pEC50值分别为8.31和8.44。

Losartan potassium (DuP-753 potassium) 是一种血管紧张素 II 受体 1 型(AT1)拮抗剂，能够与血管紧张素 II 与 AT1 的结合竞争,其 IC50=20 nM。

Captopril (SA333) 是一种含巯基的，具有口服活性的血管紧张素转换酶(ACE)抑制剂 ，IC50=0.025 μM，广泛应用于高血压和充血性心力衰竭的研究。Captopril 也是NDM-1抑制剂，IC50=7.9 μM。

Perindopril erbumine (S9490-3) 是一种长效血管紧张素转换酶抑制剂。

Olmesartan (RNH 6270) 是一种血管紧张素 II 受体 (AT1R) 拮抗剂，常用于研究高血压。

Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It selectively and competitively blocks the binding of angiotensin II to the angiotensin I receptor.

Pivalopril is a new orally active inhibitor of angiotensin-converting enzyme.

PD 109488 is a metabolite of quinapril and is a derivative of Quinapril that acts as an ACE inhibitor. Inhibition of ACE prevents the conversion of signaling peptide angiotensin I into angiotensin II, which acts as a potent vasoconstrictor. Reduced levels of angiotensin II also reduces the amount of aldosterone that is expressed due to RAAS signaling.

Angiotensin I-13C6,15N (human, mouse, rat) TFA 是经过13C 和15N 标记的蛋白质,具体为Angiotensin I (human, mouse, rat) TFA 的同位素标记形式。此化合物作为angiotensin II的前体，在血管紧张素转化酶 (ACE) 的作用下被裂解, 产生angiotensin II。

Quinapril是一种可口服的非肽和非巯基血管紧张素转换酶（ACE）抑制剂。它专门阻止血浆与组织中的血管紧张素I向血管紧张素II的转换。Quinapril通过酶水解生成具有药理活性的Quinaprilat，对高血压模型具有疗效。

Quinaprilat是一种具有口服活性的ACE抑制剂，Quinapril的活性代谢物，和OAT3的底物。Quinaprilat能够阻断angiotensin I向angiotensin II的转化，具有抗高血压活性。

Angiotensin I/II (1-7) amide is a peptide analog to angiotensin II that is used as a vasopressor in the treatment of certain types of shock and circulatory collapse. Angiotensin I/II amide is an amide derivative of angiotensin II that is a powerful vasoco

Angiotensin I/II (2-7) is a peptide that contains the amino acids 2-7 and is converted from Angiotensin I/II peptide. Angiotensin is a peptide hormone that causes vasoconstriction and a subsequent increase in blood pressure. Angiotensin also stimulates th

Angiotensin Fragment 1-7 is a type 1 angiotensin II receptor agonist. In the renin-angiotensin system, angiotensin I is cleaved by the angiotensin-converting enzyme to form angiotensin II, which has effects on fluid and electrolyte, as well as homeostasis

Delapril hydrochloride (indalapril) 是一种血管紧张素转化酶抑制剂，能够用于心血管疾病的研究。

Delapril is an ACE inhibitor. It blocks the conversion of angiotensin I to angiotensin II.

Imidapril (TA-6366 free base) 是口服有效的血管紧张素转换酶（ACE）和MMP-9抑制剂。Imidapril 通过抑制血管紧张素 I 向血管紧张素 II 转化从而降低总外周阻力和血压。Imidapril 在高血压、1 型糖尿病、肾病和慢性心力衰竭中有研究价值。